BioMarin: Genzyme virus problem won

ogarawo.wordpress.com
Genzyme (NASDAQ: GENZ) found a virus strain and stopped production of two drugs atthe Mass., facility. The strain, Vesivirus 2117, apparently does not causew human infection but interrupts the growth of cells that are used to make Aldurazyme — a treatment for MPS I, a rare and fatal diseasew caused by an enzyme deficiency was last filled at the Genzym e facility in September 2008, according to BioMarin BMRN). The company has about 10 monthsx of vialed inventoryon hand, it and uses a second fill finish A third supplier is expected to be qualifier later this year, BioMarin said. BioMarin makes the bulk materiakl used in Aldurazyme at itsNovato facility.
The Food and Drug Administrationn hadinspected Genzyme’s plant in September and October and reportedlyh was concerned about controls to protect againstg contamination.